IL-17 and colorectal cancer: From carcinogenesis to treatment
- 23 January 2019
- journal article
- review article
- Published by Elsevier BV in Cytokine
- Vol. 116, 7-12
- https://doi.org/10.1016/j.cyto.2018.12.021
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Interleukin-17: A Promoter in Colorectal Cancer ProgressionClinical and Developmental Immunology, 2013
- TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cellsMolecular Cancer, 2013
- Small molecule inhibitors of RORγt: Targeting Th17 cells and other applicationsEuropean Journal of Immunology, 2012
- Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)–dependent TGF-β signalingProceedings of the National Academy of Sciences of the United States of America, 2011
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligandNature, 2011
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activityNature, 2011
- Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon AdenocarcinomaClinical Cancer Research, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor MicroenvironmentCancer Cell, 2009
- Cancer-related inflammationNature, 2008